Lincoln Pharmaceuticals Limited has informed the Exchange regarding 'Appointment of Secretarial Auditor of the Company'.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has appointed M/s Ankit Sethi & Associates, a peer-reviewed practicing Company Secretaries firm, as its Secretarial Auditor. The appointment is for a 5-year term covering FY2025-26 to FY2029-30 (April 1, 2025 to March 31, 2030), subject to shareholder approval at the upcoming Annual General Meeting. The firm is led by Mr. Ankit Sethi, who has over 10 years of experience in listed company compliances, secretarial audits, due diligence, and corporate restructuring. The appointment was recommended by the Audit Committee and approved by the Board on August 7, 2025, and is made to comply with Section 204 of the Companies Act, 2013 and Regulation 24A of SEBI Listing Regulations.
This is a routine compliance appointment and is unlikely to have any material impact on the stock price or shareholders. It simply ensures the company meets regulatory requirements for secretarial auditing over the next five years.